China's drug authority said Thursday it had approved two more coronavirus vaccines made by domestic companies for public use, as reported in This is Money.
The National Medical Products Administration said vaccines made by CanSino Biologics and a unit of Sinopharm were given conditional approvals after they were found protective against COVID-19.
China has now approved four domestic vaccines, after approving Sinovac's CoronaVac candidate earlier this month, and another Sinopharm product in December.
Meanwhile, the Chinese drug agency also said Thursday it would require both licence holders to "continue carrying out relevant research, complete the conditional requirements, and submit follow-up research results in a timely manner."
To read more NewsPoints articles, click here.